Freedom to Operate
Quickly and efficiently completed freedom-to-operate analyses of multiple complex multi-step chemical synthesis proposals received from our client’s potential business partners, thereby enabling prompt, business-critical decisions related to development of their new cancer drug.
Provided freedom-to-operate analysis, competitive landscape analysis and strategic analysis and advice on patentability including the likely scope of a 3rd party medical device patent application being considered for license by our client, thereby enabling the client to reassess the business value of the technology and eliminate the high cost of maintaining an option to license.
Portfolio Strategy and Development
Developed and successfully executed a strategy to obtain multi-patent protection of methods of therapeutic use of our client’s lead biological drug, including corresponding patent coverage internationally, thereby extending the commercial life of the product in the face of expiring composition of matter patents.